Oasys vs. Extreme H20 Xtra 59

Phase 4

Completed

• Conditions: Dry Eye
• Interventions: Drug: Restasis, Refresh Endura

• Registration Number: NCT00477763
• Lead Sponsor: Innovative Medical

Brief Summary

To compare the performance of Oasys to Extreme H20 xtra 59 in dry eye contact lens pts who receive Restasis in 1 eye and vehicle (Endura) in the other eye.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-05
• Study First Submitted: 2007-05-21
• Study First Submitted QC: 2007-05-22
• Study First Posted: 2007-05-24
• Status Verified: 2008-02
• Primary Completion: 2008-02
• Study Completion: 2008-02
• Last Update Submitted: 2008-02-13
• Last Update Posted: 2008-02-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

• Male or Female at least 19 years of age
• Contact Lens Wearers
• Patients with mild to moderate symptoms of dry eye

Exclusion Criteria

• male or female younger than 19 years of age

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	Restasis, Refresh Endura	-
2	Restasis, Refresh Endura	-

Primary Outcome Measures

Name	Time	Method
comparing performance of contact lens	10 months

Secondary Outcome Measures

Name	Time	Method
Dry eye	10 months

Trial Locations

Locations (1)

Hazleton Eye Specialists; 🇺🇸 Hazleton, Pennsylvania, United States